RecruitingNot ApplicableNCT05218811

Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach

Cryotherapy and Robotic Assisted Non Ischemic Nephron Sparring Surgery


Sponsor

Urological Research Network, LLC

Enrollment

150 participants

Start Date

May 15, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

Patients with renal masses eligible to partial nephrectomy often require arterial ischemia to control or prevent blood loss during this surgical procedure. This study aims to determine the safety and efficacy of renal cryoablation at the tumor bed, as a substitute measure or technique vs total or selective arterial renal ischemia.


Eligibility

Min Age: 55 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a new surgical approach for removing kidney tumors using cryoablation (freezing) to reduce bleeding during the operation — a technique called cryoablation-assisted partial nephrectomy. The goal is to preserve as much of the healthy kidney as possible while avoiding the need to temporarily cut off blood supply during surgery. **You may be eligible if...** - You are between 45 and 90 years old - You have a kidney tumor that is 7 cm or smaller - More than half of the tumor protrudes outside the kidney (exophytic) **You may NOT be eligible if...** - You have had prior surgery on the same kidney - Your cancer has spread beyond the kidney (metastatic disease) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECryoablation Assisted Partial Nephrectomy

Cryoablation Assisted Partial Nephrectomy is monitored under Ultrasound guidance, A Cryoablation machine (FDA Approved Device) along with its Cryoprobes are used in the study The Cryoprobes are placed in close to the endophytic tumor margins. The tumor boundary area will undergo one freezing cycles. Tumor is excised after 5 minutes of freezing cycle. Thawing process is passive, renal defect repair is conducted during thawing process.


Locations(1)

Urological Research Network

Miami Lakes, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05218811


Related Trials